Thursday, February 20, 2020

US FDA News: FDA Announces Collaborative Review of Scientific Evidence to Support Associations Between Genetic Information and Specific Medications

FDA is providing its view of the state of the current science in pharmacogenetics. FDA’s new web-based resource describes some of the gene-drug interactions for which it believes there is sufficient scientific evidence to support associations between certain genetic variants & specific medications.
Read more: FDA Announces Collaborative Review of Scientific Evidence to Support Associations Between Genetic Information and Specific Medications